vaccines

News

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

Missing the primary endpoint in a phase 3 trial will not stop Pfizer from submitting Valneva-partnered Lyme disease vaccine for approval.

News

Hope rises for vaccine against hookworm parasite

Pivotal trials are being prepared for the Na-GST 1/Al–CpG vaccine, which could help address a parasite affecting hundreds of millions of people.

News

Meningitis outbreak in UK prompts call to widen vaccination

A UK patient group is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent killed two young people.

News

US judge rules Kennedy's vaccine changes 'unlawful'

A US judge has stymied attempts by HHS Secretary Kennedy to change immunisation policy, stopping this week's vaccine advisory panel from going ahead.

News

GSK's RSV shot cleared in US for all adults

GSK is back on level pegging with its rivals in the RSV vaccine category in the US, after getting FDA approval for Arexvy in the 18 to 49 age bracket.

News

Moderna agrees $950m settlement of mRNA jab litigation

Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.

Pfizer, Valneva shrug off phase 3 Lyme disease vaccine miss

Hope rises for vaccine against hookworm parasite

Meningitis outbreak in UK prompts call to widen vaccination

US judge rules Kennedy's vaccine changes 'unlawful'

GSK's RSV shot cleared in US for all adults

Moderna agrees $950m settlement of mRNA jab litigation

LSX2026: On promise and patience, with Hans Schambye

Using AI-driven synthetic personas to take your insights fur...

vaccines

Editor's Picks